开发口服瘤学不坚持估计器 (ORACLE):对口服瘤学药物的治疗前不坚持风险评估
Jessie Signorelli1, Thuy Tran2, Marie E Sirek3
1Pharmacy, Massachusetts General Hospital, Boston, MA, USA.
概括
一个新的工具估计了在治疗开始前不坚持口服瘤学药物的风险. 这有助于临床医生主动支持化疗患者.
科学领域:
- 在瘤学瘤学.
- 患者坚持的研究研究.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 没有现有的工具估计了口服瘤学药物不坚持的风险.
- 口服瘤学需要主动的坚持管理策略.
研究的目的:
- 开发和描述一种新的风险评估工具,用于口腔瘤学不坚持.
- 确定影响患者遵守口腔癌治疗的关键因素.
主要方法:
- 文献审查以确定坚持障碍和相关问卷项目.
- 工作组由国家社区瘤分发协会组建.
- 为自动化风险分类而开发的电子调查工具.
主要成果:
- 确定了六个关键因素:患者的信心,健康素养,治疗感知,生活质量,社会支持和治疗方案的复杂性.
- 创建了一个六项调查问卷 (五名患者,一名临床医生).
- 答案按一个10分系统进行索引,将风险分为低,中等或高.
结论:
- 在开始口服抗瘤药物治疗之前,需要一个经过验证的工具来预测不坚持.
- 该工具旨在指导临床医生实施遵守管理策略.
- 未来的步骤包括临床验证和试验.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
Assessment of the Mouth
220
A thorough mouth assessment, including inspection and palpation of the lips, gums, tongue, tonsils, uvula, and pharynx, is crucial in detecting potential health issues. Diseases ranging from oral cancer to systemic conditions like diabetes could be identified early through careful oral examination. This article provides a detailed guide on conducting a comprehensive mouth assessment.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
220
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
82
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
82
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357


